Transfusion medicine plays a vital role in the supportive care of patients receiving therapy
for hematology, oncology and hematopoietic stem cell transplants (HSCT). With advances in …

Allogeneic hematopoietic stem cell transplantation (AHSCT) is an intention-to-cure treatment
strategy in several malignancies and nonmalignancies. The number of patients receiving …

The recommendations of the French Health and Drug Safety Authorities (HAS/ANSM-Haute
Autorité de santé/Agence nationale de sécurité du médicament) are known, but there are …

Transfusion support for cancer patients, with hematological or oncological problems, is a
multifaceted challenging medical intervention for clinicians. Management strategies must …

Transfusion support is a major therapy for many patients with hematologic and oncologic
disorders. However, given their frequent exposure and often immunosuppressed state, they …

Background Transfusion support in haematopoietic stem cell transplantation (HSCT) can be
very demanding and challenging. The conditioning regimen, stem cell dose, donor type …

Hematopoietic stem cell patients regularly require transfusion support. Indications for
transfusion in this population are similar to other patients being treated with chemoradiation; …

Allogeneic blood transfusion (ABT) therapy plays a major role in the case of patients with
cancer. Packed red blood cells (PRBC) are given for increased oxygen-carrying capacity …

The increased use of hematopoietic progenitor cell (HPC) transplantation has implications
and consequences for transfusion services: not only in hospitals where HPC …

Transfusion support for hematopoietic stem cell transplantation (HSCT) is an essential part
of supportive care, and compatible blood should be transfused into recipients. As leukocyte …